DEBORAH SHELDON: Open Payments
NPI 1649538448 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 19 payments from 12 companies in 2025. Trend: 2023 $300 · 2024 $609 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Genentech USA, Inc. | 2 | $51 |
| ARGENX US, INC. | 2 | $46 |
| Fresenius USA Marketing, Inc. | 2 | $35 |
| Vifor Pharma, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Travere Therapeutics, Inc. | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: Kerendia, Ocrevus Zunovo, VELPHORO, Veltassa, EOHILIA, AUSTEDO XR, VOQUEZNA, TREMFYA.
Industry payments across NE — which companies pay providers there.
